660837-08-1

Basic information

• Product Name: 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diaMine
• Synonyms: 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diaMine;2-(2-Methyl-5-aminophenylamino)-4-(3-pyridyl)thiazole;4-Methyl-N3-[4-(3-pyridinyl)-2-thiazolyl]-1,3-benzenediamine;6-methyl-N1-(5-(pyridin-3-yl)thiazol-2-yl)benzene-1,3-diamine
• CAS NO: 660837-08-1
• Molecular Formula: C₁₅H₁₄N₄S
• Molecular Weight: 282.36346
• Mol File: 660837-08-1.mol

Chemical Properties

• Boiling Point: 509.391 °C at 760 mmHg
• Flash Point: 261.87 °C
• Appearance: /
• Density: 1.312 g/cm³
• PKA: 4.69±0.10(Predicted)
• CAS DataBase Reference: 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diaMine(660837-08-1)
• EPA Substance Registry System: 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diaMine(660837-08-1)

Safety Data

• Hazardous Substances Data: 660837-08-1(Hazardous Substances Data)

Usage

Uses

Used in Scientific Research:
4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diamine is used as a research compound for exploring its chemical properties and potential interactions with biological systems. Its unique structure may offer insights into new areas of study and contribute to the development of novel applications in the fields of biochemistry and pharmacology.
Used in Biochemical Research:
In the field of biochemistry, 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diamine is used as a model compound to study its reactivity and binding affinity with various biomolecules. This research may lead to a better understanding of its potential role in biological processes and the discovery of new biochemical pathways.
Used in Pharmacological Studies:
4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diamine is used as a candidate compound in pharmacological studies, where it may be evaluated for its potential therapeutic effects and interactions with drug targets. Its unique structure could potentially lead to the development of new drugs or therapeutic agents with novel mechanisms of action.
Used in Drug Development:
In the pharmaceutical industry, 4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diamine is used as a starting material for the synthesis of new drug candidates. Its structural characteristics may provide a basis for the design of innovative therapeutic agents with improved efficacy and safety profiles.
Used in Chemical Synthesis:
4-Methyl-n3-(4-pyridin-3-yl-thiazol-2-yl)-benzene-1,3-diamine is used as a key intermediate in the synthesis of complex organic molecules and compounds. Its unique structure may enable the development of new synthetic routes and the creation of novel chemical entities with potential applications in various industries.

Upstream product

• 1048007-94-8 N-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)thiazol-2-amine 
• 17694-68-7 3-(2-bromoacetyl)pyridine hydrobromide 
• 99-55-8 2-methyl-5-nitroaniline 
• 790299-78-4 2-methyl-5-tert-butoxycarbonylaminoaniline hydrobromide salt 
• 660838-06-2 N-(2-methyl-5-tert-butoxycarbonylamino)phenyl-thiourea 
• 350-03-8 methyl-3-pyridylketone 

Downstream Products

• 790299-79-5 masitinib 

Relevant articles and documents

A novel benzoyl amide compounds

The invention relates to the field of medicinal chemistry, in particular to a novel benzamides compound or a salt acceptable in parmacy of the novel benzamides compound, a preparation method of the novel benzamides compound, a pharmaceutical composition containing the novel benzamides compound and an application of the pharmaceutical composition in preparation of antineoplastic drugs.

2,3-dimethyl-6-urea -2H-indazoles and its preparation method and application

The invention discloses a 2, 3-dimethyl-6-urea-2H-indazole compound shown by the following general formula (I), medicinal salt or a solvent compound thereof, wherein Ar is substituted or unsubstituted phenyl or aromatic matrix. The invention also discloses a preparation method and application of the compound. The compound can regulate signal transduction of tyrosine kinase, inhibit bad cellular proliferation, and particularly has obvious curative effect for tumors.

PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS AS KINASE INHIBITORS

The present invention relates to an industrial process of preparing pharmaceutical compounds having the formula (I) which are useful as certain tyrosine kinase inhibitors and more particularly as c-kit and bcr-abl inhibitors. The groups R1 and R2, identical or different, represent each a hydrogen, halogen atom, an alkyl, an alkoxy, a trifluoromethyl, an amino, an alkylamino, a dialkylamino, a solubilising group; m is 0-5 and n is 0-4; the group R3 represents an aryl or an heteroaryl group as described in claims herein.

USE OF C-KIT INHIBITORS FOR TREATING TYPE II DIABETES

The present invention relates to a method for treating type II diabetes, comprising administering a compound capable of depleting mast cells to a human in need of such treatment. Such compounds can be chosen from non-toxic, selective and potent c-kit inhibitors.

2-(3-AMINOARYL) AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS

The present invention relates to the use of masitinib or a pharmaceutically acceptable salt thereof, and in particular of masitinib mesylate, for the preparation of a medicament for the treatment of GIST, to the use of this therapy for the treatment of GIST, and a method of treating mammals, including humans, suffering from GIST by administering to said mammal in need of such treatment an effective dose of masitinib, and in particular masitinib mesylate